IRPSX | VIVIX | IRPSX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 36 years | 26 years | - |
Gain YTD | 12.000 | 19.673 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 361M | 184B | 0% |
Annual Yield % from dividends | 1.65 | 2.37 | 70% |
Returns for 1 year | 19.37 | 26.09 | 74% |
Returns for 3 years | 1.36 | 24.77 | 5% |
Returns for 5 years | 5.70 | 53.09 | 11% |
Returns for 10 years | -14.93 | 112.27 | -13% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LOMGX | 33.64 | 0.67 | +2.03% |
Lord Abbett Growth Opportunities F3 | |||
MASCX | 12.68 | 0.06 | +0.48% |
BlackRock Sustainable Advantage GlEqInvA | |||
ASYLX | 16.09 | 0.06 | +0.37% |
AB Select US Long/Short Advisor | |||
VCDAX | 187.95 | 0.53 | +0.28% |
Vanguard Consumer Discretionary Idx Adm | |||
WIEFX | 14.27 | N/A | N/A |
Boston Trust Walden International Eq |